The response of the regional cerebral blood flow (rCBF) to brain topical superfusion of 20 mM K + was characterized in a closed cranial window preparation in barbiturate anesthetized and ventilated rats: Increasing K + in the artificial cerebrospinal fluid (ACSF) induced a rCBF elevation (measured by laser-Doppler flowmetry) of + 85 ± 37% above baseline (n = 19), This elevation was stable for > 3 h with continuous superfusion of in creased K + (n = 5) and partially reversible to a level of + 18 ± 19% above baseline when returning to a physio logical K + concentration, Nitric oxide synthase (NOS) inhibition by brain topical superfusion with Nw-nitro-L arginine (L-NA) revealed (a) Addition of L-NA to high potassium ACSF reduced the rCBF increase from + 94 ± 36% to +21 ± 18%(p",, 0,01,n = 7). (b) When L-NA was superfused for 60 min before increasing K +, rCBF de creased to -17 ± 7% below baseline. Subsequent coap plication of L-NA and increased K + induced only an el evation of + 7 ± 4% above baseline (n = 4). (c) When the
Potassium has long been discussed as a mediator of the coupling of cerebral metabolism and blood flow (Lubbers and Leniger-Follert, 1978; Iadecola and Kraig, 1991) . K + is released by active neurons, transported through astrocytes, and released onto blood vessels (Paulson and Newman, 1987) . Pial ar teries respond to moderate elevations (up to 20 mM) of the local K + concentration with vasodilation (Kuschinsky et aI., 1972) . Regional cerebral blood flow (rCBF) increases with elevation of extracellu-NO donor S-nitroso-N-acetylpenicillamine (SNAP) was added during NOS inhibition to restore basal tissue NO levels, the resultant level of rCBF was + 28 ± 54% above baseline. Subsequent increase of K + in the presence of NOS inhibition and SNAP elevated rCBF to + 137 ± 89% above baseline (n = 4). Statistical analysis comparing K + -induced elevation of rCBF (a) without any added drugs, (b) in the presence of NOS inhibition with L-NA, and (c) in the presence of both NOS inhibition and SNAP revealed,that K + -induced elevation in the presence of NOS inhibition was significantly reduced (p "" 0.05) whereas no statistical difference was found between K +induced elevation of rCBF without drugs compared with the K + -induced elevation of rCBF in the presence of L-NA and SNAP. We conclude that NO is a modulator of the rCBF elevation to increased extracellular K + concen tration. Key Words: Laser-Doppler flowmetry-Cranial window-Microcirculation-Coupling. lar potassium concentration ([K + ]0) in this range (Iadecola and Kraig, 1991) . This vasodilation is probably mediated by the Na + -K + -ATPase and by inward rectifier K + channels of vascular smooth muscle (Edwards et aI., 1988; McCarron and Halp ern, 1990; Toda, 1976; Webb and Bohr, 1978) .
Apart from potassium, another important candi date in the coupling of cerebral metabolism and blood flow is nitric oxide (NO) (Dirnagl et aI., 1993; Iadecola, 1993; ladecola et aI., 1994a) . Rapoport and Murad (1983) have demonstrated a synergistic relaxation of rat aorta by moderate elevation of the [K +]0 and sodium nitroprusside, a NO donor. In addition they showed that relaxation to sodium ni troprusside was inhibited by K + free solution, in dicating an interaction of NO and K + in vascular smooth muscle. Based on these results, the aim of this study was to test whether NO is involved in elevation of rCBF by increased [K +]0' METHODS Male Wistar rats (n = 27; 250-300 g) were anes thetized with 100 mg/kg body weight thiopental so dium (Trapanal, BYK Pharmaceuticals, Konstanz, Germany), tracheotomized, and artificially venti lated (Effenberger Rodent Respirator, Effenberger Med.-Techn. Geratebau, Pfaffing/Attel, Germany). The left femoral artery and vein were cannulated, and a continuous i. v. saline infusion (l ml/h) was started. Body temperature was maintained at 38 ± OSC with a heating pad. Systemic arterial pressure (RFT Biomonitor, Germany) and end-expiratory Pco2 (Heyer co2 Monitor EGM I, Bad Ems, Ger many) were monitored. Pao2, Paco2, and pH were measured serially using a Compact 1 Blood Gas An alyzer (AVL Medizintechnik GmbH, Bad Hom burg, Germany). Anesthesia was maintained with thiopental sodium throughout the experiment.
A craniotomy was performed (4 x 5 mm) over the right parietal cortex using a saline-cooled drill; the dura mater was removed; and a closed cranial win dow was implanted (for details, see Lindauer et aI. , 1993) . The cortical surface under the window was continuously superfused with artificial cerebrospi nal fluid (ACSF) at a superfusion rate of 5 mllh. The composition of the ACSF in mM was: Ca 2 + 1. 5; Mg 2 + 1. 2; HC0 3 -24. 5; Cl-135; glucose 3. 7; urea 6. 7. The K + concentrations (3 and 20 mM) deter mined the Na T concentrations (152 and 135 mM). The ACSF was equilibrated with a gas mixture con taining 6. 6% 0 2 ' 5.9% CO 2 , and 87. 5% N 2 leading to a P0 2 of 129. 1 ± 12. 0 mm Hg, a Pco2 of 33. 4 ± 4.6 mm Hg, and pH of 7. 38 ± 0. 04. rCBF was measured with a laser-Doppler flow probe (Vasamedics BPM 403 A, Troy, MI, U.S.A. ) permitting continuous monitoring of rCBF with a spatial resolution of � 1 mm 3 and a temporal resolution of 0. 1 s (Dirnagl et aI. , 1989) . Systemic arterial pressure, rCBF, and end-expiratory Pco2 were recorded continuously using a PC running the ASYST (Macmillan Soft ware, New York) data acquisition software.
Five series were performed (see Fig. I for exper imental paradigm). In all series, a stable rCBF base line was first obtained over 5 min. After wash-in of drugs dissolved in ACSF and/or change of the K + concentration of the ACSF ([K +]ACSF)' rCBF was recorded again and the relative change from base line was calculated. In series 1 (n = 7) we tested whether the K + -induced rCBF elevation could be attenuated with Nw-nitro-L-arginine (L-NA) (Sigma Chemicals, Deisenhofen, Germany) with a serial test paradigm. At first the [K +]ACSF was elevated from 3 to 20 mM. Then L-NA was applied in a con centration of 1 mM for 60 min. This protocol re- duces NOS enzyme activity in the cortex beneath the cranial window by >80% (Irikura et aI., 1994; Zhang and ladecola, 1994) . In the presence of L-NA, [K +]ACSF was then lowered again to a con centration of 3 mM. In series 2 (n = 7), we elevated [K + ]ACSF from 3 to 20 mM and subsequently low ered [K]ACSF back to the physiological level to eval uate to what extent the rCBF change induced by K + is reversible. In series 3 (n = 5) we elevated [K + ]ACSF over a period of 3 h to test the stability of the K + -induced rCBF change. For the comparison of the K T -induced elevation of rCBF in the absence and presence of L-NA, we started in series 4 with application of L-N A and subsequently elevated [K T]ACSF from 3 to 20 mM (n = 4). In series 5, we studied whether the K + -induced elevation of rCBF can be restored by S-nitroso-N-acetylpenicillamine (SNAP) (Research Biochemicals International, Natick, MA, U.S.A.), a NO donor, despite NOS inhibition (n = 4). In this series L-NA was first washed in. SNAP was added subsequently in a con centration to titrate rCBF to a level close to base line (100 f.lM-l mM). Then lK +]ACSF was elevated in the presence of NOS inhibition from 3 to 20 mM. After 60 min, SNAP was reapplied in the same con centration as before. SNAP was washed in twice because its effect starts to disappear after 20-40 min.
Data were analyzed comparing relative changes of rCBF. The comparison between K + -induced el evation of rCBF (a) without any added drugs, (b) in the presence of NOS inhibition, and (c) in the pres ence of NOS inhibition and SNAP was made using a one-way analysis of variance with the Tukey test ( Fig. 2) (SPSS-PC, SPSS Inc., Chicago, IL, U.S.A.). Mean value comparisons from one appli cation to the following in series 1, 2, and 3 were performed with paired t tests (Fig. 3) .
RESULTS
In Table 1 , physiological variables before and at the end of the experiment are given. They were also continuously measured in between. The physiolog ical variables were within normal limits within all series. Neither topical application of L-NA nor of SNAP had any influence on systemic variables.
The following data were obtained for the CBF response to extracellular potassium elevation. In creasing the [K + ]ACSF from 3 to 20 mM elevated rCBF by + 85 ± 36% above baseline (data from series 1,2, and 3, n = 19, p � 0.01). An effect was evident after � 20-min wash-in and maximal after 25-35 min. A complete effect was observed after 60 min. This K -r -induced elevation of rCBF was par tially reversible (reduction from + 78 ± 34% to + 18 ± 19% above baseline, series 2, n = 7, P � 0.01) when K + was lowered back to a physiological level. The K + -induced elevation of rCBF was stable over a period of at least 3 h with continuous superfusion of increased K + (n = 5). Major fluctuations of rCBF in the presence of increased K + were not observed.
NOS inhibition with topical application of L-NA revealed the following. (a) Addition of L-NA to the ACSF with increased [K + ]ACSF reduced the rCBF elevation from + 94 ± 36% to + 21 ± 18% above baseline (series 1, n = 7, p � 0.01, Fig. 2) . When the increased [K + ]ACSF was subsequently lowered back to a physiological level in the presence of NOS inhibition, rCBF further decreased to -1 ± 17% below baseline (series I,n = 7,p�0.01, Fig.2 ). (b) Superfusion with L-N A for 60 min before increasing K+ decreases rCBF to -17 ± 7% below baseline. Subsequent coapplication of L-NA and increased K + induced only an elevation of rCBF to + 7 ± 4% above baseline (series 4, n = 4). (c) When the NO donor SNAP was added during NOS inhibition to restore basal tissue NO levels, the resultant level of rCBF was + 28 ± 54% above baseline. Subsequent increase of K + in the presence of NOS inhibition and SNAP elevated rCBF to + 137 ± 89% above baseline (series 5, n = 4). Statistical analysis comparing K + -induced eleva tion of rCBF (a) without any added drugs (data from series 1,2, and 3), (b) in the presence of NOS inhi bition (data from series 4), and (c) in the presence of both NOS inhibition and SNAP (data from series 5) revealed that K + -induced elevation in the presence of NOS inhibition was significantly reduced (Fig. 3 , p :S 0.05), whereas no statistical difference was found between K + -induced elevation of rCBF with out any added drugs compared with K + -induced elevation of rCBF in the presence of L-NA and SNAP. In the text, we have reported the relative CBF values related to a CBF baseline before drug application. For the statistical analysis of the rela tive rCBF changes induced by 20 mM K + (Fig. 3) , the rCBF levels in the presence of 3 mM K + after drug application were used as baseline. For the sta tistical analysis, this procedure is more precise be cause the K + -independent effects of L-NA and of the combination of L-NA and SNAP, respectively, are considered. In any case, both ways of data rep resentation lead to statistical significances with p :S 0.05.
DISCUSSION
We have measured an increase of rCBF by mod erate elevation of [K + ]ACSF to + 85 ± 36% above baseline, confirming data from ladecola and Kraig (1991) . In their experiments, topical application of 20 mM K + for a similar application time was asso ciated with elevation of the [K + 10 in brain cortex by -11 mM in a depth of 750 f.Lm below the brain sur face. We demonstrated that the K + -induced eleva tion of rCBF remained stable for at least 3 h. When L-NA was added, rCBF was diminished to a similar level as with reduction of the [K + ]ACSF to a phys iological range without addition of L-NA. Consis tently, the K + -induced elevation of rCBF in the presence of NOS inhibition was significantly atten-uated. When the NO donor SNAP was applied, the K + -induced elevation of rCBF was restored despite NOS inhibition. Thus, NO seems to be a permissive factor for the K + -induced elevation of rCBF.
Potassium accumulates in the extracellular space as a result of neural activation (ladecola and Kraig, 1991; Dietzel et ai., 1980; Dreier and Heinemann, 1991; Paulson and Newman, 1987) . However, an elevation of [K +]0 alone is not sufficient to increase rCBF to a similar level as does neural electrical stimulation (ladecola and Kraig, 1991) . It has been shown that NOS inhibition can reduce elevation of rCBF associated with vibrissae stimulation, indicat ing a prominent role of NO in the coupling between cerebral metabolism and blood flow (Dirnagl et aI., 1993 (Dirnagl et aI., , 1994 Irikura et aI., 1994) . On the basis of our data, it seems possible that K + and NO work syn ergistically in this process. A synergistic action of sodium nitroprusside, another NO donor, on K + dependent relaxation of isolated rings from rat aorta has been shown by Rapoport and Murad (1983) .
It is not clear what mechanism may underlie the interaction between K + and NO. Two hyperpolar izing mechanisms in vascular smooth muscle may be responsible for K + -induced cerebral vasodila tion: In the lower range of the elevation in [K +]0 (>5 mM) stimulation of the electrogenic sodium pump has been implicated because the Na + -K + ATPase inhibitor ouabain abolishes transient dila tions induced by elevation of [K +]0' In the higher range of [K +]0 (> 7 mM), activation of inwardly rectifiying K + channels is deduced from the cur rent-voltage relationship of the membrane poten tial, the relationship between [K +]0 and membrane potential, and the blockade of the hyperpolarization by barium and cesium (McCarron and Halpern, 1990; Edwards et aI., 1988; Toda, 1976; Webb and Bohr, 1978) . However, cerebral artery dilation to [K +]0 > 7 mM can also be blocked by ouabain even though at somewhat higher concentrations of oua bain, suggesting a role of the Na + -K + -ATPase (McCarron and Halpern, 1990) . Interestingly, an in hibiting effect of ouabain on relaxation of aortic rings by sodium nitroprusside and 8-bromo-cyclic GMP, a cyclic GMP analog, has also been described (Rapoport and Murad, 1983) , possibly linking K + to NO via the Na + -K + -ATPase.
However, various other more general NO-related mechanisms of smooth-muscle relaxation could be involved, as follows.
1. Calcium-related mechanisms such as plasma membrane Ca 2 + influx, sarcoplasmatic reticulum Ca 2 + release, and plasma membrane Ca 2 + extru sion (Hester, 1985; Godfriand and Miller, 1985; Karaki et aI., 1986; Taylor and Meisheri, 1986) or 2. Calcium-independent mechanisms (Yanagi sawa et aI., 1989; Chabaud et aI., 1994; Dietrich et aI., 1994; Ito et aI., 1991) possibly via a second ex citation-contraction pathway in vascular smooth muscle involving calcium-independent protein ki nase C isoforms (Khalil et aI., 1992; Chabaud et aI., 1994) or cyclic-GMP-mediated dissociation of acto myosin latch bridges (Sarcevic et aI., 1989) or 3. Mechanisms related to potassium channels. To our knowledge, an interaction of NO with inwardly rectifying K + channels has not been described yet. However, NO is discussed as a modulator of other potassium channels in vascular smooth muscle, e.g., calcium-dependent K -t-channels (Bolotina et aI., 1994; Khan et aI., 1993; Robertson et aI., 1993) . The action of NO and acetylcholine on A TP sensitive K + channels in vascular smooth muscle is controversial (McPherson and Angus, 1991; Par sons et aI., 1991; Miyoshi et aI., 1994) .
The final common pathway for the control of vas cular reactivity and, ultimately, regulation of blood flow, lies at the level of the vascular smooth-mus cle cell. However, in our in vivo model, besides direct effects of NOS inhibition and potassium ele vation on vascular smooth muscle, secondary ef fects via undefined vasoactive products released from glial, neuronal, and endothelial cells have to be considered. In this respect, the time delay be tween wash-in of elevated potassium and CBF in crease seems important. We would expect the ap pearance of a &rect effect of K + on pial arteries plus the equilibration time of the ACSF under the cranial window to take <20 min. On the other hand, more distal arteriolar segments require higher concentrations of K + than more proximal segments do to give maximal membrane hyperpolarization due to activation of inwardly rectifying potassium J Cereb Blood Flow Mefab. Vol. 15. No.6, 1995 channels (Edwards et aI., 1988) , In this range of K + concentration (10 mM), more proximal seg ments already begin to depolarize due to the change of the potassium equilibrium potential. Therefore, it may be that a prominent part of the arteriolar targets for K + -induced elevation of CBF lie within the cortex, and it is necessary for K + to diffuse into the tissue, where glial potassium clearance mecha nisms will delay the effect (Paulson and Newman, 1987) .
Compared with other anesthetics such as halo thane, thiobutabarbiturates significantly reduce the CBF response to somatosensory stimulation (Lin dauer et aI., 1993) . To our knowledge, the existing findings suggest that this suppression of the CBF response is likely to be the result of neuronal sup pression due to increased inhibition via a prolonged opening time of the GABAA-receptor-associated Cl-channel (MacDonald and McLean, 1986 ) and interference with synaptosomal and synaptoneuro somal second-messenger systems (Deshmukh et aI., 1991) . Thus, barbiturate-induced neuronal suppres sion may affect the neuronal release of K + on so matosensory stimul -ation. However, in our experi ments K + was given topically, and a suppression of neuronal activity is therefore unlikely to interfere with our results. It has been reported that barbitu rates affect endothelium-derived relaxing factor mediated hyperemia to a cholinergic agonist (Stur aitis et aI., 1994) . However, both our CBF response to L-NA and SNAP demonstrate that direct action of NO on the vasculature is preserved despite an esthesia with thiopental sodium.
We have reported here that blockade of NOS strongly attenuates the K + -induced elevation of rCBF. The K + -induced elevation of rCBF in the presence of NOS inhibition is restored by applica tion of an NO donor. Hypercapnic cerebrovasodi lation has also been shown to be attenuated by NOS inhibition (N iwa et aI., 1993; Iadecola et aI., 1994b) and is also restored by application of NO donors, indicating a permissive role of NO (Iadecola et aI., 1994b) . Furthermore, the adenosine-induced eleva tion of rCBF may also be NO dependent (Dirnagl et aI., 1994) . Combining the evidence from our study with the literature, the question arises whether the disturbance of a central mechanism requiring NO is responsible for the attenuation of the rCBF re sponse to the different factors K + , H + , and aden osine during NOS inhibition or whether specific in teractions exist. This will be addressed in future studies.
